Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (305)	2/20/2003 1:30:51 PM
From: Jibacoa	Respond to of 3722

CTIC Is up 10.2% on volume of more than 557K (more than 100K ahead of its daily average.) It reported earnings today (which included $55.3M from "gain on exchange of convertible subordinated notes" that helped it to report income for the year of $0.88.share vs. a 2001 loss of $0.95/share.(Without that "extraordinary gain" the loss in 2002 would have been $0.76/share.) For the 4th Q the sales of its Trisenox injection rose more than 70% to $4M from $2.3M in the 4th Q of 2001. They said that they expect the Trisenox sales trend to continue, and that will help CTIC to reach its goal of $24M in product sales in 2003 and have a profitable commercial unit by year end.<g> They also said that management will present at several conferences in February and March.<g> The shares are trading today above the 6 level.<g> siliconinvestor.com The stock needs to close above the Jan.30-Jan.31 double top at the 6.70 level siliconinvestor.com The December H at 9.85 is a more important resistance, but that would be a good % gain from present levels.<g> The stock seems to have good support at the 5.20 level. siliconinvestor.com Bernard